Oliver Lawson

Oliver Lawson
T: +44 (0) 20 7246 0531
E: oliver.lawson@alantra.com

Oliver (Oli) is an Associate and has over six years' experience in finance, M&A and transaction services.

He works alongside our Partners and Directors to deliver all types of deals including company acquisitions and disposals, management buy-outs (MBOs), fund raisings and strategic reviews, acting for business owners, management teams, corporates and private equity.​ 

Oli is a member of our Consumer sector team. Recent deals include advising the founder of Ape Snacks, the UK-based coconut snacks brand, on its exit to a private investor and brand owner operating in the food and beverage space; advising the founders of premium chocolate brand Montezuma’s on its sale to Inverleith; and the £80 million sale of The Sloane Club.

He graduated from Loughborough University with a degree in Business Economics & Finance. He qualified as a chartered accountant with PwC whilst working in audit before moving to Transaction Services, spending time in both the Birmingham and London offices, with a focus on the retail, consumer and leisure sectors.

Away from work Oli is a keen sportsman, especially when it comes to rugby, cricket and skiing. His other main passion is the countryside, where in another life he would have stayed at home working on the family farm in Somerset.

 

Alantra appoints experienced partner to head up its UK Real Estate & Hospitality team

Alantra has appointed Hoong Wey Woon as a Partner to head up its UK Real Estate & Hospitality team.  

Alantra advises Strong Roots on securing over €15.5m of investment

Alantra advises Strong Roots, one of the UK’s fastest-growing food companies, on securing over €15.5m of investment 

Alantra advises i2S on its sale to Gfi Informatique

Alantra advises Portuguese IT firm, i2S, on its sale to Gfi Informatique 

Alantra expands its technology sector team with two senior appointments

Alantra has expanded its Technology Media and Telecoms (TMT) sector team with two senior appointments. James Chapman-Andrews joins as Partner and Head of UK TMT and Simon Devonshire OBE, joins as Technology Industry Adviser.  

Alantra advises on sale of 3P Biopharmaceuticals to Keensight Capital

We advised Cinfa and the rest of the shareholders on the sale of 3P Biopharmaceuticals to Keensight Capital, a European growth private equity fund with deep expertise in healthcare.